- Home
- SSY vs GOVX Comparison
SSY vs GOVX Comparison
Compare SSY & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- GOVX
- Stock Information
- Founded
- SSY 1959
- GOVX 2001
- Country
- SSY United States
- GOVX United States
- Employees
- SSY N/A
- GOVX N/A
- Industry
- SSY Hospital/Nursing Management
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- GOVX Health Care
- Exchange
- SSY Nasdaq
- GOVX Nasdaq
- Market Cap
- SSY 6.8M
- GOVX 7.6M
- IPO Year
- SSY N/A
- GOVX N/A
- Fundamental
- Price
- SSY $1.04
- GOVX $0.72
- Analyst Decision
- SSY
- GOVX Strong Buy
- Analyst Count
- SSY 0
- GOVX 4
- Target Price
- SSY N/A
- GOVX $10.50
- AVG Volume (30 Days)
- SSY 235.5K
- GOVX 2.1M
- Earning Date
- SSY 09-29-2025
- GOVX 07-28-2025
- Dividend Yield
- SSY 9.62%
- GOVX N/A
- EPS Growth
- SSY N/A
- GOVX N/A
- EPS
- SSY 0.25
- GOVX N/A
- Revenue
- SSY $31,094,000.00
- GOVX $6,143,044.00
- Revenue This Year
- SSY N/A
- GOVX N/A
- Revenue Next Year
- SSY N/A
- GOVX N/A
- P/E Ratio
- SSY $4.24
- GOVX N/A
- Revenue Growth
- SSY N/A
- GOVX 1943.07
- 52 Week Low
- SSY $0.62
- GOVX $0.43
- 52 Week High
- SSY $1.91
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- SSY 46.09
- GOVX 44.46
- Support Level
- SSY $1.02
- GOVX $0.72
- Resistance Level
- SSY $1.44
- GOVX $0.83
- Average True Range (ATR)
- SSY 0.15
- GOVX 0.07
- MACD
- SSY -0.01
- GOVX 0.01
- Stochastic Oscillator
- SSY 16.67
- GOVX 19.96
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.